Biomerica (BMRA) FCF Margin Growth (3y) (2013 - 2026)
Biomerica (BMRA) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 60.00 |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 2,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2,916.00 |
| Nov 30, 2025 | 157.00 |
| Aug 31, 2025 | 7,875.00 |
| May 31, 2025 | -751.00 |
| Feb 28, 2025 | -12,398.00 |
| Nov 30, 2024 | 1,391.00 |
| Aug 31, 2024 | -7,998.00 |
| May 31, 2024 | 266.00 |
| Feb 29, 2024 | -13,826.00 |
| Nov 30, 2023 | 4,097.00 |
| Aug 31, 2023 | 4,415.00 |
| May 31, 2023 | 4,154.00 |
| Feb 28, 2023 | -11,686.00 |
| Nov 30, 2022 | -6,079.00 |
| Aug 31, 2022 | -9,730.00 |
| May 31, 2022 | 628.00 |
| Feb 28, 2022 | 5,252.00 |
| Nov 30, 2021 | -4,498.00 |
| Aug 31, 2021 | 6,804.00 |
| May 31, 2021 | -6,492.00 |